Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE -Schedule of Earnings (Loss) Per Share (Details)

v3.23.2
EARNINGS (LOSS) PER SHARE -Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Net income (loss) $ 93,687 $ 523,054 $ 256,580 $ (491,975) $ 616,741 $ (235,395)
Dividends on preferred stock (1,278)   (1,380)   (2,585) (2,828)
Participating securities - preferred stock (14,044)   (39,590)   (92,611) 0
Net income (loss) attributable to common stockholders 78,365   215,610   521,545 (238,223)
Re-allocation of participating securities 182   310   1,008 0
Diluted net income (loss) attributable to common stockholders $ 78,547   $ 215,920   $ 522,553 $ (238,223)
Basic shares (in shares) 18,518,000   20,684,000   18,688,000 20,961,000
Dilutive shares (in shares) 18,805,000   20,877,000   18,930,000 20,961,000
Basic EPS (in usd per share) $ 4.23   $ 10.42   $ 27.91 $ (11.36)
Dilutive EPS (in usd per share) $ 4.18   $ 10.34   $ 27.60 $ (11.36)
Restricted Stock            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Dilutive shares (in shares) 300,000   200,000   200,000 0
Anti-dilutive shares (in shares)           200,000
Series A Convertible Preferred Stock            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Anti-dilutive shares (in shares) 3,300,000   3,800,000   3,300,000 3,800,000